Regen BioPharma Update on Orphan Drug Application for HemaXellerate Will Be Presented At Emerging Growth Conference on September 24, 2025
Regen Biopharma, Inc. Common (RGBP)
NASDAQ:AMEX Investor Relations:
regenbiopharmainc.com/investor-relations.html
Company Research
Source: GlobeNewswire
SAN DIEGO, Sept. 23, 2025 (GLOBE NEWSWIRE) -- Regen BioPharma, Inc. (OTC PINK: RGBP) and (OTC PINK: RGBPP) today announced the Company will be presenting an update on its application for Orphan Drug status to the U.S. Food and Drug Administration (FDA) for HemaXellerate. This therapy is anticipated being used in treating aplastic anemia. Additionally the Company anticipates HemaXellerate may be used in addressing the side effects of Chemotherapy, a market of several billions of dollars. The Company’s Chairman and CEO, Dr. Koos said he will be making the update on the Orphan Drug Application and answering questions from the audience. The Company has stated it is poised to move into Clinical Phase I with HemaXellerate, which has already been cleared by the FDA. If you would like to participate in the conference or ask questions, please use the link: https://goto.webcasts.com/starthere.jsp?ei=1717091&tp_key=c78a55764a&sti=rgbp to register. The conference presentation will start at 4:
Show less
Read more
Impact Snapshot
Event Time:
RGBP
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
RGBP alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
RGBP alerts
High impacting Regen Biopharma, Inc. Common news events
Weekly update
A roundup of the hottest topics
RGBP
Sec Filings
- 12/4/25 - Form QUALIF
- 11/17/25 - Form 1-A
- 11/13/25 - Form 8-K
- RGBP's page on the SEC website